Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL Trial.
Olde Nordkamp LRA. et al, (2025), Circulation
Real-time Smartphone Alerts During Atrial Fibrillation Episodes with Implantable Cardiac Monitors and Wearable Devices: SMART-ALERT study.
Briosa E Gala A. et al, (2025), Heart Rhythm
Identifying extra pulmonary vein targets for persistent atrial fibrillation ablation: bridging advanced and conventional mapping techniques.
Sharp AJ. et al, (2025), Europace, 27
Multi-modal integration of MRI and global chamber charge density mapping for the evaluation of atrial fibrillation.
Sharp AJ. et al, (2025), R Soc Open Sci, 12
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trial
de Veld JA. et al, (2025), Heart Rhythm O2
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Olde Nordkamp LRA. et al, (2024), Circ Arrhythm Electrophysiol
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.
Knops RE. et al, (2024), Circ Cardiovasc Qual Outcomes, 17
"Real-world" performance of the Confirm Rx™ SharpSense AF detection algorithm: UK Confirm Rx study.
Gala ABE. et al, (2024), J Arrhythm, 40, 1093 - 1101
Role of impedance drop and lesion size index (LSI) to guide catheter ablation for atrial fibrillation.
Leo M. et al, (2024), Pacing Clin Electrophysiol, 47, 1404 - 1411
The effect of sodium-glucose co-transporter 2 inhibitors on outcomes after cardiac resynchronization therapy.
Bray JJH. et al, (2024), ESC Heart Fail, 11, 2314 - 2322
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure.
Singh JP. et al, (2024), JAMA Cardiol
Leveraging 3D Atrial Geometry for the Evaluation of Atrial Fibrillation: A Comprehensive Review.
Sharp AJ. et al, (2024), J Clin Med, 13
Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement
Betts TR. et al, (2024), Arrhythmia & Electrophysiology Review, 13
Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement
Betts TR. et al, (2024), Interventional Cardiology: Reviews, Research, Resources, 19
Cardiac resynchronization using fusion pacing during exercise.
Green PG. et al, (2023), J Cardiovasc Electrophysiol
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria.
Dasí A. et al, (2023), J Physiol, 601, 4013 - 4032
Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results.
Starek Z. et al, (2023), Europace, 25